| Literature DB >> 28414199 |
Yi Shi1, Xiao-Xi Wang1, You-Wen Zhuang1, Yi Jiang1, Karsten Melcher2, H Eric Xu1,2.
Abstract
The polycomb repressive complexes 2 (PRC2) complex catalyzes tri-methylation of histone H3 lysine 27 (H3K27), a repressive chromatin marker associated with gene silencing. Overexpression and mutations of PRC2 are found in a wide variety of cancers, making the catalytic activity of PRC2 an important target of cancer therapy. This review highlights recent structural breakthroughs of the human PRC2 complex bound to the H3K27 peptide and a small molecule inhibitor, which provide critically needed insight into PRC2-targeted drug discovery.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28414199 PMCID: PMC5519257 DOI: 10.1038/aps.2017.7
Source DB: PubMed Journal: Acta Pharmacol Sin ISSN: 1671-4083 Impact factor: 6.150